- Home
- HBCP vs HRTX Comparison
HBCP vs HRTX Comparison
Compare HBCP & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBCP
- HRTX
- Stock Information
- Founded
- HBCP 1908
- HRTX 1983
- Country
- HBCP United States
- HRTX United States
- Employees
- HBCP N/A
- HRTX N/A
- Industry
- HBCP Banks
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- HBCP Finance
- HRTX Health Care
- Exchange
- HBCP Nasdaq
- HRTX Nasdaq
- Market Cap
- HBCP 342.0M
- HRTX 350.4M
- IPO Year
- HBCP 2008
- HRTX 1987
- Fundamental
- Price
- HBCP $50.94
- HRTX $2.11
- Analyst Decision
- HBCP Buy
- HRTX Strong Buy
- Analyst Count
- HBCP 2
- HRTX 2
- Target Price
- HBCP $57.50
- HRTX $5.50
- AVG Volume (30 Days)
- HBCP 23.3K
- HRTX 1.8M
- Earning Date
- HBCP 04-21-2025
- HRTX 05-06-2025
- Dividend Yield
- HBCP 2.06%
- HRTX N/A
- EPS Growth
- HBCP 0.90
- HRTX N/A
- EPS
- HBCP 4.78
- HRTX N/A
- Revenue
- HBCP $135,421,000.00
- HRTX $148,518,000.00
- Revenue This Year
- HBCP $2.54
- HRTX $11.18
- Revenue Next Year
- HBCP $4.69
- HRTX $13.15
- P/E Ratio
- HBCP $10.66
- HRTX N/A
- Revenue Growth
- HBCP 3.44
- HRTX 12.43
- 52 Week Low
- HBCP $35.16
- HRTX $1.04
- 52 Week High
- HBCP $52.77
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- HBCP 64.96
- HRTX 47.04
- Support Level
- HBCP $49.42
- HRTX $2.00
- Resistance Level
- HBCP $51.42
- HRTX $2.61
- Average True Range (ATR)
- HBCP 1.69
- HRTX 0.18
- MACD
- HBCP 0.23
- HRTX -0.01
- Stochastic Oscillator
- HBCP 93.58
- HRTX 20.63
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.